⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 3, 2018Science ImmunologyOpen Access

RORα-expressing T regulatory cells restrain allergic skin inflammation

View Full Paper

Ask AI

Bookmark

Share

Abstract

in humans, suggesting that RORα and the TL1A-DR3 circuit could be therapeutically targeted in atopic dermatitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Leyva-Castillo et al. (2018) studied this question.

synapsesocial.com/papers/6aa72088bb64cafef81b3948 https://doi.org/10.1126/sciimmunol.aao6923

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionOriginal Research · 2007 · 2,492 citations
2TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin InflammationOriginal Research · 2013 · 737 citations
3Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.Original Research · 1998 · 646 citations
4Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammationOriginal Research · 2010 · 165 citations
5Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitisOriginal Research · 2016 · 69 citations